Protein kinase a in cancer

Cancers

Volumn 3, Issue 1, 2011, Pages 913-926

  Caretta, Antonio ^a   Mucignat Caretta, Carla ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

cAMP; Cancer; Diagnosis; PKA; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMATINIB;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CELL CYCLE REGULATION; CELL FUNCTION; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME LOCALIZATION; ENZYME MODIFICATION; ENZYME REGULATION; GENE EXPRESSION; GENETIC DISORDER; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN VARIANT; REGULATORY MECHANISM; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 79953725149     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3010913     Document Type: Review

References (94)

1. Ren, R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat. Rev. Cancer 2005, 5, 172-183.
2. Rall, T.W.; Sutherland, E.W. Formation of a cyclic adenine ribonucleotide by tissue particles. J. Biol. Chem. 1958, 232, 1065-1076.
3. Chin, K.V.; Yang, W.L.; Ravatn, R.; Kita, T.; Reitman, E.; Vettori, D.; Cvijic, M.E.; Shin, M.; Iacono, L. Reinventing the wheel of cyclic AMP: Novel mechanisms of cAMP signaling. Ann. NY Acad. Sci. 2002, 968, 49-64.
4. Rogue, P.J.; Humbert, J.P.; Meyer, A.; Freyermuth, S.; Krady, M.M.; Malviya, A.N. cAMP-dependent protein kinase phosphorylates and activates nuclear Ca2+-ATPase. Proc. Natl. Acad. Sci. USA 1998, 95, 9178-9183.
5. David, M.; Petricoin, E., III; Larner, A.C. Activation of protein kinase A inhibits interferon induction of the Jak/Stat pathway in U266 cells. J. Biol. Chem. 1996, 271, 4585-4588.
6. Cook, S.J.; McCormick, F. Inhibition by cAMP of Ras-dependent activation of Raf. Science 1993, 262, 1069-1072.
7. Biel, M. Cyclic nucleotide-regulated cation channels. J. Biol. Chem. 2009, 284, 9017-9021.
8. Walsh, D.A.; Perkins, J.P.; Krebs, E.G. An adenosine 3'5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. J. Biol. Chem. 1968, 243, 3763-3765.
9. Cadd, G.; McKnight, G.S. Distinct patterns of cAMP dependent protein kinase gene expression in mouse brain. Neuron 1989, 3, 71-79.
10. Taylor, S.S.; Kim, C.; Cheng, C.Y.; Brown, S.H.J.; Wu, J.; Kannan, N. Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design. Biochim. Biophys. Acta 2008, 1784, 16-26.
11. Rich, T.C.; Fagan, K.A.; Tse, T.E.; Schaack, J.; Cooper, D.M.; Karpen, J.W. A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell. Proc. Natl. Acad. Sci. USA 2001, 98, 13049-13054.
12. Steinberg, S.F.; Brunton, L.L. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Ann. Rev. Pharmacol. Toxicol. 2001, 41, 751-773.
13. Donelson Smith, F.; Langeberg, L.K.; Scott, J.D. The where's and when's of kinase anchoring. Trends Biochem. Sci. 2006, 31, 316-323.
14. Beene, D.L.; Scott, J.D. A-kinase anchoring proteins take shape. Curr. Opin. Cell Biol. 2007, 19, 192-198.
15. Mucignat-Caretta, C.; Caretta, A. Binding of two fluorescent cAMP analogues to type I and II regulatory subunits of cAMP-dependent protein kinases. Biochim. Biophys. Acta 1997, 1357, 81-90.
16. Mucignat-Caretta, C.; Conti, V.; Caretta, A. cAMP-dependent protein kinase type RI is found in clusters in the rat detergent-insoluble neuronal fraction. Neurosci. Lett. 1999, 273, 1-4.
17. Mucignat-Caretta, C.; Caretta, A. Visualization of detergent insoluble cyclic AMP-dependent protein kinase RIalpha aggregates in the rat brain. Brain Res. Brain Res. Protoc. 2001A, 6, 185-189.
18. Mucignat-Caretta, C. Aggregates of cAMP-dependent kinase RID characterize a type of cholinergic neurons in the rat brain. Mol. Brain Res. 2000, 80, 233-236.
19. Mucignat-Caretta, C.; Caretta, A. Localization of Triton-insoluble cAMP-dependent kinase type RIbeta in rat and mouse brain. J. Neurocytol. 2001B, 30, 885-894.
20. Mucignat-Caretta, C.; Caretta, A. Clustered distribution of cAMP-dependent protein kinase regulatory isoform RIalpha during the development of the rat brain. J. Comp. Neurol. 2002, 451, 324-333.
21. Mucignat-Caretta, C.; Caretta, A. Regional variations in the localization of insoluble kinase A regulatory isoforms during rodent brain development. J. Chem. Neuroanat. 2004A, 27, 201-212.
22. Mucignat-Caretta, C.; Caretta, A. Distribution of insoluble cAMP-dependent kinase type RI and RII in the lizard and turtle central nervous system. Brain Res. 2007, 1154, 84-94.
23. Mucignat-Caretta, C.; Bondi, M.; Caretta, A. Animal models of depression: Olfactory lesions affect amygdala, subventricular zone and aggression. Neurobiol. Dis. 2004B, 16, 386-395.
24. Stork, P.J.; Schmitt, J.M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002, 12, 258-266.
25. Ferrari, S. Protein kinases controlling the onset of mitosis. Cell. Mol. Life Sci. 2006, 63, 781-795.
26. Hochbaum, D.; Hong, K.; Barila, G.; Ribeiro-Neto, F.; Altschuler, D.L. Epac, in sinergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis. J. Biol. Chem. 2008, 283, 4464-4468.
27. Vossler, M.R.; Yao, H.; York, R.D.; Pan, M.G.; Rim, S.; Stork, P.J. cAMP activates MAP kinase and Elk-1 through a B-Raf-and Rap1-dependent pathway. Cell 1997, 89, 73-82.
28. Boulogne, B.; Habert, R.; Levacher, C. Regulation of the proliferation of cocultured gonocytes and Sertoli cells by retinoids, triiodothyronine, and intracellular signaling factors: differences between fetal and neonatal cells. Mol. Reprod. Dev. 2003, 65, 194-203.
29. Sevetson, B.R.; Kong, X.; Lawrence, J.C., Jr. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 1993, 90, 10305-10309.
30. Chen, J.; Iyengar, R. Suppression of Ras-induced transformation of NIH 3T3 cells by activated G alphas. Science 1994, 263, 1278-1281.
31. Sato, S.; Sugimura, T.; Yoda, K.; Fujimura, S. Morphological differentiation of cultured mouse glioblastoma cells induced by dibutyryl cyclic adenosine monophosphate. Cancer Res. 1975, 35, 2494-2499.
32. Moreno, M.J.; Ball, M.; Andrade, M.F.; McDermid, A.; Stanimirovic, D.B. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells. Glia 2006, 53, 845-857.
33. Prasad, K.N.; Cole, W.C.; Yan, X.D.; Nahreini, P.; Kumar, B.; Hanson, A.; Prasad, J.E. Defects in cAMP-pathway may initiate carcinogenesis in dividing nerve cells: A review. Apoptosis 2003, 8, 579-586.
34. Sillibourne, J.E.; Milne, D.M.; Takahashi, M.; Ono, Y.; Meek, D.W. Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450. J. Mol. Biol. 2002, 322, 785-797.
35. Nigg, E.A.; Raff, J.W. Centrioles, centrosomes, and cilia in health and disease. Cell 2009, 139, 663-678.
36. Landsverk, H.B.; Carlson, C.R.; Steen, R.L.; Vossebein, L.; Herberg, F.W.; Tasken, K.; Collas, P. Regulation of anchoring of the RIIalpha regulatory subunit of PKA to AKAP95 by threonine phosphorylation of RIIalpha: implications for chromosome dynamics at mitosis. J. Cell Sci. 2001, 114, 3255-3264.
37. Benetti, L; Roizman, B. Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis. Proc. Natl. Acad. Sci. USA 2004, 101, 9411-9416.
38. Waschek, J.A.; Dicicco-Bloom, E.; Nicot, A.; Lelievre, V. Hedgehog signaling: New targets for GPCRs coupled to cAMP and protein kinase A. Ann. NY Acad. Sci. 2006, 1070, 120-128.
39. Chiaradonna, F.; Balestrieri, C.; Gaglio, D.; Vanoni, M. RAS and PKA pathways in cancer: New insight from transcriptional analysis. Front. Biosci. 2008, 13, 5257-5278.
40. Neary, C.L.; Nesterova, M.; Cho, Y.S.; Becker, K.G.; Cho-Chung, Y.S. Protein kinase A isozyme switching: Eliciting differential cAMP signalling and tumor reversion. Oncogene 2004, 23, 8847-8856.
41. Schwede, F.; Maronde, E.; Genieser, H.G.; Jastorff, B. Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol. Ther. 2000, 87, 199-226.
42. Kirschner, L.S.; Carney, J.A.; Pack, S.D.; Taymans, S.E.; Giatzakis, C.; Cho, Y.S.; Cho-Chung, Y.S.; Stratakis, C.A. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat. Genet. 2000, 26, 89-92.
43. Bossis, I; Stratakis, C.A. PRKAR1A: Normal and abnormal functions. Endocrinology 2004, 145, 5452-5458.
44. Nadella, K.S.; Kirschner, L.S. Disruption of protein kinase A regulation causes immortalization and dysregulation of D-type cyclins. Cancer Res. 2005, 65, 10307-10315.
45. Porter, S.E.; Dwyer-Nield, L.D.; Malkinson, A.M. Regulation of lung epithelial cell morphology by cAMP-dependent protein kinase type I isozyme. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280, L1282-L1289.
46. Cho-Chung, Y.S.; Nesterova, M.; Becker, K.G.; Srivastava, R.; Park, Y.G.; Lee, Y.N.; Cho, Y.S.; Kim, M.K.; Neary, C.; Cheadle, C. Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: antisense, microarray, gene overexpression, and transcription factor decoy. Ann. NY Acad. Sci. 2002, 968, 22-36.
47. Loeffler, I.; Gruen, M.; Boehmer, F.D.; Rubio, I. Role of cAMP in the promotion of colorectal cancer cell growth by prostaglandin E2. BMC Cancer 2008, 8, 380.
48. Mantovani, G.; Lania, A.G.; Bondioni, S.; Peverelli, E.; Pedroni, C.; Ferrero, S.; Pellegrini, C.; Vicentini, L.; Arnadi, G.; Bosari, S.; Beck-Peccoz, P.; Spada, A. Different expression of protein kinase A (PKA) regulatory subunits in cortisol secreting adrenocortical tumors: Relationship with cell proliferation. Exp. Cell Res. 2008, 314, 123-130.
49. Merkle, D.; Hoffmann, R. Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: Cross-talk with the androgen receptor. Cell Signal. 2011, 23, 507-515.
50. Uren, A.; Toretsky, J.A. Pediatric malignancies provide unique cancer therapy targets. Curr. Opin. Pediatr. 2005, 17, 14-21.
51. Tysnes, B.B.; Mahesparan, R. Biological mechanisms of glioma invasion and potential therapeutic targets. J. Neurooncol. 2001, 53, 129-147.
52. Frattola, L.; Canal, N.; Ferrarese, C.; Tonini, C.; Tonon, G.; Villani, R.; Trabucchi, M. Multiple forms of protein kinase from normal human brain and glioblastoma. Cancer Res. 1983, 43, 1321-1324.
53. Schwartz, J.P.; Costa, E. Protein kinase translocation following beta-adrenergic receptor activation in C6 glioma cells. J. Biol. Chem. 1980, 255, 2943-2948.
54. Chen, T.C.; Hinton, D.R.; Zidovetzki, R.; Hofman, F.M. Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab. Invest. 1998, 78, 165-174.
55. Hoelzinger, D.B.; Mariani, L.; Weis, J.; Woyke, T.; Berens, T.J.; McDonough, W.S.; Sloan, A.; Coons, S.W.; Berens, M.E. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 2005, 7, 7-16.
56. Odreman, F.; Vindigni, M.; Gonzales, M.L.; Niccolini, B.; Candiano, G.; Zanotti, B.; Srap, M.; Pizzolitto, S.; Stanta, G.; Vindigni, A. Proteomic studies on low-and high-grade human brain astrocytomas. J. Proteome Res. 2005, 4, 698-708.
57. Mucignat-Caretta, C.; Cavaggioni, A.; Redaelli, M.; Malatesta, M.; Zancanaro, C.; Caretta, A. Selective distribution of protein kinase A regulatory subunit RIIalpha in rodent gliomas. Neuro-Oncology 2008, 10, 958-967.
58. Ichimura, K.; Ohgaki, H.; Kleihues, P.; Collins, V.P. Molecular pathogenesis of astrocytic tumours. J. Neurooncol. 2004, 70, 137-160.
59. Jang, I.S.; Juhnn, Y.S. Adaptation of cAMP signaling system in SH-SY5Y neuroblastoma cells following expression of a constitutively active stimulatory G protein alpha, Q227L Gsalpha. Exp. Mol. Med. 2001, 33, 37-45.
60. Hanson, A.J.; Nahreini, P.; Andreatta, C.; Yan, X.D.; Prasad, K.N. Role of the adenosine 3',5'-cyclic monophosphate (cAMP) in enhancing the efficacy of siRNA-mediated gene silencing in neuroblastoma cells. Oncogene 2005, 24, 4149-4154.
61. Doskeland, S.O.; Maronde, E.; Gjertsen, B.T. The genetic subtypes of cAMP-dependent protein kinase-functionally different or redundant? Biochim. Biophys. Acta 1993, 1178, 249-258.
62. Chen, T.C.; Wadsten, P.; Su, S.; Rawlinson, N.; Hofman, F.M.; Hill, C.K.; Schoenthal, A.H. The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells. Cancer Biol. Ther. 2002, 1, 268-276.
63. Li, Y.; Yin, W.; Wang, X.; Zhu, W.; Huang, Y.; Yan, G. Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway. Proc. Natl. Acad. Sci. USA 2007, 104, 13438-13443.
64. Hu, W.; Onuma, T.; Birukawa, N.; Abe, M.; Ito, E.; Chen, Z.; Urano, A. Change of morphology and cytoskeletal protein gene expression during dibutyryl cAMP-induced differentiation in C6 glioma cells. Cell. Mol. Neurobiol. 2008, 28, 519-528.
65. Lee, J.K.; Choi, M.R.; Song, D.K.; Huh, S.O.; Kim, Y.H.; Suh, H.W. Activation of adenylate cyclase results in down-regulation of c-jun mRNA expression in rat C6 glioma cells. Neurosci. Lett. 1999, 276, 53-56.
66. Anciaux, K.; Van Dommelen, K.; Nicolai, S.; Van Mechelen, E.; Slegers, H. Cyclic AMP-mediated induction of the glial fibrillary acidic protein is independent of protein kinase A activation in rat C6 glioma. J. Neurosci. Res. 1997, 48, 324-333.
67. Oh-hashi, K.; Hirata, Y.; Koga, H.; Kiuchi, K. GRP78-binding protein regulates cAMP-induced glial fibrillary acidic protein expression in rat C6 glioblastoma cells. FEBS Lett. 2006, 580, 3943-3947.
68. Wechsler-Reya, R.J.; Scott, M.P. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 1999, 22, 103-114.
69. Moriuchi, S.; Shimizu, K.; Miyao, Y.; Kishima, H.; Okawa, M.; Hayakawa, T. Decreased N-myc expression in human medulloblastoma cell lines during differentiation. Anticancer Res. 1997, 17, 301-306.
70. Kobsar, A.; Heeg, S.; Krohne, K.; Opitz, A.; Walter, U.; Boeck, M.; Gambaryan, S.; Eigenthaler, M. Cyclic nucleotide-regulated proliferation and differentiation vary in human hematopoietic progenitor cells derived from healthy persons, tumor patients, and chronic myelocytic leukemia patients. Stem Cells Dev. 2008, 17, 81-91.
71. Zurawel, R.H.; Allen, C.; Chiappa, S.; Cato, W.; Biegel, J.; Cogen, P.; de Sauvage, F.; Raffel, C. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Gen. Chrom. Cancer 2000, 27, 44-51.
72. Katoh, Y.; Katoh, M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signalling activation. Curr. Mol. Med. 2009, 9, 873-886.
73. Asaoka, Y.; Kanai, F; Ichimura, T.; Tateishi, K.; Tanaka, Y.; Ohta, M.; Seto, M.; Tada, M.; Ijiichi, H.; Ikenoue, T.; Kawabe, T.; Isobe, T.; Yaffe, M.B.; Omata, M. Identification of a suppressive mechanism for Hedgehog signalling through a novel interaction of Gli with 14-3-3. J. Biol. Chem. 2010, 285, 4185-4194.
74. Schueller, U.; Koch, A.; Hartmann, W.; Garre', M.L.; Goodyer, C.G.; Cama, A.; Sorensen, N.; Wiestler, O.D.; Pietsch, T. Subtype-specific expression and genetic alterations of the chemokine receptor gene CXCR4 in medulloblastomas. Int. J. Cancer 2005, 117, 82-89.
75. Yang, L.; Jackson, E.; Woerner, B.M.; Perry, A.; Piwnica-Worms, D.; Rubin, J.B. Blocking CXCR4-mediated cAMP suppression inhibits brain tumor growth in vivo. Cancer Res. 2007, 67, 651-658.
76. Mucignat-Caretta, C.; Denaro, L.; Redaelli, M.; D'Avella, D.; Caretta, A. Protein kinase A regulatory subunit distribution in medulloblastoma. BMC Cancer 2010, 10, 141.
77. Howe, A.K. Regulation of actin-based cell migration by cAMP/PKA. Biochim. Biophys. Acta 2004, 1692, 159-174.
78. Jiang, P.; Enomoto, A.; Takahashi, M. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett. 2009, 284, 122-130.
79. Tortora, G.; Ciardiello, F.; Pepe, S.; Tagliaferri, P.; Ruggiero, A.; Bianco, C.; Guarrasi, R.; Mik, K.; Bianco, A.R. Phase I clinical study with 8-Chloro-cAMP and evaluation of immunological effects in cancer patients. Clin. Cancer Res. 1995, 1, 377-384.
80. Tortora, G.; Ciardiello, F. Protein kinase A as target for novel integrated strategies of cancer therapy. Ann. NY Acad. Sci. 2002, 968, 139-147.
81. Tortora, G.; Caputo, R.; Damiano, V.; Melisi, D.; Bianco, R.; Fontanini, G.; Veneziani, B.M.; De Placido, S.; Bianco, A.R.; Ciardiello, F. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1 839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. Clin. Cancer Res. 2003, 9, 1566-1572.
82. Hirsh, L.; Dantes, A.; Suh, B.S.; Yoshida, Y.; Hosokawa, K.; Tajima, K.; Kotsuji, F.; Merimsky, O.; Amsterdam, A. Phosphodiesterase inhibitors as anti-cancer drugs. Biochem. Pharmacol. 2004, 68, 981-988.
83. Goldhoff, P.; Warrington, N.; Limbrick, D.D., Jr.; Hope, A.; Woerner, B.M.; Jackson, E.; Perry, A.; Piwnica-Worms, D.; Rubin, J.B. Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression. Clin. Cancer Res. 2008, 14, 7717-7725.
84. Russo, P.; Catassi, A.; Cesario, A.; Servent, D. Development of novel therapeutic strategies for lung cancer: targeting the cholinergic system. Curr. Med. Chem. 2006, 13, 3493-3512.
85. Erikstein, B.S.; McCormack, E.; Tronstad K.J.; Schwede, F.; Berge, R.; Gjertsen, B.T. Protein kinase A activators and the pan-PPAR agonist tetradecylthioacetic acid elicit synergistic anti-leukaemic effects in AML through CREB. Leuk. Res. 2010, 34, 77-84.
86. Gao, N.; Hibi, Y.; Cueno, M.; Asamitsu, K.; Okamoto, T. A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling. J. Biol. Chem. 2010, 285, 28097-28104.
87. Mani, S.; Goel, S.; Nesterova, M.; Martin, R.M.; Grindel, J.M.; Rothenberg, M.L.; Zhang, R.; Tortora, G.; Cho-Chung, Y.S. Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I. Ann. NY Acad. Sci. 2003, 1002, 252-262.
88. Hensley, H.H.; Hannoun-Levi, J.M.; Hachem, P.; Mu, Z.; Stoyanova, R.; Khor, L.Y.; Agrawal, S.; Pollack, A. PKA knockdown enhances cell killing in response to radiation and androgen deprivation. Int. J. Cancer 2011, 128, 962-973.
89. Mantovani, G.; Bondioni, S.; Ferrero, S.; Gamba, B.; Ferrante, E.; Peverelli, E.; Corbetta, S.; Locatelli, M.; Rampini, P.; Beck-Peccoz, P.; Spada, A.; Lania, A.G. Effect of cyclic adenosine 3',5'-monophosphate/protein kinase A pathway on markers of cell proliferation in non-functioning pituitary adenomas. J. Clin. Endocrinol. Metab. 2005, 90, 6721-6724.
90. Horvath, A.; Bertherat, J.; Groussin, L.; Guillaud-Bataille, M.; Tsang, K.; Cazabat, L.; Libè, R.; Remmers, E.; Renè-Corail, F.; Faucz, F.R.; Clauser, E.; Calender, A.; Bertagna, X.; Carney, J.A.; Stratakis, C.A. Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. Hum. Mutat. 2010, 31, 369-379.
91. Khor, L.Y.; Bae, K.; Al-Saleem, T.; Hammond, E.H.; Grignon, D.J.; Sause, W.T.; Pilepich, M.V.; Okunieff, P.P.; Sandler, H.M.; Pollack, A. Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10. Int. J. Radiat. Oncol. Biol. Phys. 2008, 71, 1309-1315.
92. Pollack, A.; Bae, K.; Khor, L.Y.; Al-Saleem, T.; Hammond, M.E.; Venkatesan, V.; Byhardt, R.W.; Asbell, S.O.; Shipley, W.U.; Sandler, H.M. The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02. Clin. Cancer Res. 2009, 15, 5478-5484.
93. Nesterova, M.V.; Johnson, M.; Cheadel, C.; Bates, S.E.; Mani, S.; Stratakis, C.A.; Khan, I.U.; Gupta, R.K.; Cho-Chung, Y.S. Autoantibody cancer biomarker: Extracellular proterin kinase A. Cancer Res. 2006, 66, 8971-8974.
94. Wang, H.; Li, M.; Lin, W.; Wang, W.; Zhang, Z.; Rayburn, E.R.; Lu, J.; Chen, D.; Yue, X.; Shen, F.; Jiang, F.; He, J.; Wei, W.; Zeng, X.; Zhang, R. Extracellular activity of cyclic AMP-dependent protein kinase as a biomarker for human cancer detection: distribution characteristics in a normal population and cancer patients. Cancer Epidem. Biomarker. Prev. 2007, 16, 789-795.